Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection

被引:52
|
作者
Schlender, J
Zimmer, G
Herrler, G
Conzelmann, KK
机构
[1] Univ Munich, Max von Pettenkofer Inst & Gene Ctr, D-81377 Munich, Germany
[2] Sch Vet Med, Inst Virol, D-30559 Hannover, Germany
关键词
D O I
10.1128/JVI.77.8.4609-4616.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human respiratory syncytial virus (HRSV) and bovine RSV (BRSV) infect human beings and cattle in a species-specific manner. We have here analyzed the contribution of RSV envelope proteins to species-specific entry into cells. In contrast to permanent cell lines, primary cells of human or bovine origin, including differentiated respiratory epithelia, peripheral blood lymphocytes, and macrophages, showed a pronounced species-specific permissivity for HRSV and BRSV infection, respectively. Recombinant BRSV deletion mutants lacking either the small hydrophobic (SH) protein gene or both SH and the attachment glycoprotein (G) gene retained their specificity for bovine cells, whereas corresponding mutants carrying the HRSV F gene specifically infected human cells. To further narrow the responsible region of F, two reciprocal chimeric F constructs were assembled from BRSV and HRSV F1 and F2 subunits. The specificity of recombinant RSV carrying only the chimeric F proteins strictly correlated with the origin of the membrane-distal F2 domain. A contribution of G to the specificity of entry could be excluded after reintroduction of BRSV or HRSV G. Virus with F1 and G from BRSV and with only F2 from HRSV specifically infected human cells, whereas virus expressing F1 and G from HRSV and F2 from BRSV specifically infected bovine cells. The introduction of G enhanced the infectivities of both chimeric viruses to equal degrees. Thus, the role of the nominal attachment protein G is confined to facilitating infection in a non-species-specific manner, most probably by binding to cell surface glycosaminoglycans. The identification of the F2 subunit as the determinant of RSV host cell specificity facilitates identification of virus receptors and should allow for development of reagents specifically interfering with RSV entry.
引用
下载
收藏
页码:4609 / 4616
页数:8
相关论文
共 50 条
  • [1] A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV
    Turner, Tiffany M.
    Jones, Les P.
    Tompkins, S. Mark
    Tripp, Ralph A.
    JOURNAL OF VIROLOGY, 2013, 87 (19) : 10792 - 10804
  • [2] Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion
    Kahn, JS
    Schnell, MJ
    Buonocore, L
    Rose, JK
    VIROLOGY, 1999, 254 (01) : 81 - 91
  • [3] Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model
    Brakel, Kelsey A.
    Binjawadagi, Basavaraj
    French-Kim, Kristen
    Watts, Mauria
    Harder, Olivia
    Ma, Yuanmei
    Li, Jianrong
    Niewiesk, Stefan
    VACCINE, 2021, 39 (47) : 6817 - 6828
  • [4] Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
    Bergeron, Harrison C.
    Murray, Jackelyn
    Arora, Aakash
    Castrejon, Ana M. Nunez M.
    DuBois, Rebecca M.
    Anderson, Larry J.
    Kauvar, Lawrence M.
    Tripp, Ralph A.
    VIRUSES-BASEL, 2023, 15 (05):
  • [5] The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate
    Cullen, Lori McGinnes
    Luo, Bin
    Wen, Zhiyun
    Zhang, Lan
    Durr, Eberhard
    Morrison, Trudy G. G.
    JOURNAL OF VIROLOGY, 2023, 97 (01)
  • [6] Respiratory syncytial virus (RSV) loads in premature infants with and without prophylactic RSV fusion protein monoclonal antibody
    DeVincenzo, JP
    Aitken, J
    Harrison, U
    JOURNAL OF PEDIATRICS, 2003, 143 (01): : 123 - 126
  • [7] Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection
    Jordan, Robert
    Shao, Matt
    Mackman, Richard L.
    Perron, Michel
    Cihlar, Tomas
    Lewis, Sandy A.
    Eisenberg, Eugene J.
    Carey, Anne
    Strickley, Robert G.
    Chien, Jason W.
    Anderson, Mark L.
    McEligot, Heather A.
    Behrens, Nicole E.
    Gershwin, Laurel J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) : 4889 - 4900
  • [8] Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
    Louis Fries
    Vivek Shinde
    Jeffrey J. Stoddard
    D. Nigel Thomas
    Eloi Kpamegan
    Hanxin Lu
    Gale Smith
    Somia P. Hickman
    Pedro Piedra
    Gregory M. Glenn
    Immunity & Ageing, 14
  • [9] Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
    Fries, Louis
    Shinde, Vivek
    Stoddard, Jeffrey J.
    Thomas, D. Nigel
    Kpamegan, Eloi
    Lu, Hanxin
    Smith, Gale
    Hickman, Somia P.
    Piedra, Pedro
    Glenn, Gregory M.
    IMMUNITY & AGEING, 2017, 14
  • [10] Parainfluenza virus type 3 expressing the native or soluble fusion (F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection in African green monkeys
    Tang, RS
    MacPhail, M
    Schickli, JH
    Kaur, J
    Lawlor, HA
    Guzzetta, JM
    Spaete, RR
    Haller, AA
    JOURNAL OF VIROLOGY, 2004, 78 (20) : 11198 - 11207